John A. Graham
Vorstandsvorsitzender bei Zuellig Pharma Ltd. (Hong Kong)
Profil
John A.
Graham is currently the Chief Executive Officer at Zuellig Pharma Ltd.
(Hong Kong) and a Senior Architect at GH2 Architects LLC.
He was previously the Chairman & Chief Executive Officer at GlucoTrack, Inc. from 2017 to 2018, and the Chief Executive Officer at Invida Group Pte Ltd.
from 2008 to 2015.
He also worked as a Managing Director at Torreya Partners LLC.
Mr. Graham received his undergraduate degree from Imperial College London.
Aktive Positionen von John A. Graham
Unternehmen | Position | Beginn |
---|---|---|
GH2 Architects LLC
GH2 Architects LLC Engineering & ConstructionIndustrial Services GH2 Architects LLC is an architecture & engineering company. The company provides a range of architectural and engineering services as well as services for due diligence, planning and zoning, construction cost control, master planning, feasibility studies, programming, sustainable design, interiors and landscape architectures. Founded in 1972 by Stan Gralla, the company is headquartered in Tulsa, OK | Corporate Officer/Principal | 10.11.2010 |
Zuellig Pharma Ltd. (Hong Kong)
Zuellig Pharma Ltd. (Hong Kong) Pharmaceuticals: MajorHealth Technology Zuellig Pharma Ltd. offers healthcare services in Asia. It provides targeted solutions including distribution of pharmaceuticals, medical devices and clinical trial materials, sales and marketing outsourcing, patient-centred programs, and a full range of retail pharmacy services. It also provides training and support for pharmacists and creates data, digital, and disease management solutions for patients with chronic conditions. The company was founded on March 6, 1970 and is headquartered in Hong Kong. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von John A. Graham
Unternehmen | Position | Ende |
---|---|---|
GLUCOTRACK, INC. | Vorstandsvorsitzender | 31.10.2018 |
Invida Group Pte Ltd.
Invida Group Pte Ltd. Pharmaceuticals: MajorHealth Technology Invida Group Pte Ltd. Was manufactured and distributed pharmaceutical products. The company was founded in 2005 and is headquartered in Singapore. | Vorstandsvorsitzender | 01.12.2015 |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Vorstandsvorsitzender | - |
Ausbildung von John A. Graham
Imperial College London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GLUCOTRACK, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
GH2 Architects LLC
GH2 Architects LLC Engineering & ConstructionIndustrial Services GH2 Architects LLC is an architecture & engineering company. The company provides a range of architectural and engineering services as well as services for due diligence, planning and zoning, construction cost control, master planning, feasibility studies, programming, sustainable design, interiors and landscape architectures. Founded in 1972 by Stan Gralla, the company is headquartered in Tulsa, OK | Industrial Services |
Invida Group Pte Ltd.
Invida Group Pte Ltd. Pharmaceuticals: MajorHealth Technology Invida Group Pte Ltd. Was manufactured and distributed pharmaceutical products. The company was founded in 2005 and is headquartered in Singapore. | Health Technology |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Finance |
Zuellig Pharma Ltd. (Hong Kong)
Zuellig Pharma Ltd. (Hong Kong) Pharmaceuticals: MajorHealth Technology Zuellig Pharma Ltd. offers healthcare services in Asia. It provides targeted solutions including distribution of pharmaceuticals, medical devices and clinical trial materials, sales and marketing outsourcing, patient-centred programs, and a full range of retail pharmacy services. It also provides training and support for pharmacists and creates data, digital, and disease management solutions for patients with chronic conditions. The company was founded on March 6, 1970 and is headquartered in Hong Kong. | Health Technology |